United Therapeutics Corporation (UTHR) support and resistance · P/E 20, rev $1.56B
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page maps United Therapeutics Corporation (UTHR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
UTHR currently screens at market cap $23.41B and trailing P/E 20.4. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new UTHR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the UTHR quote page for the session range and the stock page for the full model.
Not investment advice.